Real-World Anti-Vascular Endothelial Growth Factor Therapy Outcomes in Myopic Choroidal Neovascularization
Devangna Bhatia, Alexander Mehta, Joanna DaCosta, Oonagh Crothers, James Stephen Talks Newcastle Eye Centre, Royal Victoria Infirmary, Newcastle upon Tyne, UKCorrespondence: Devangna BhatiaNewcastle Eye Centre, Royal Victoria Infirmary, Newcastle upon Tyne, UKEmail Devangna88@gmail.comAim: Evaluatio...
Guardado en:
Autores principales: | Bhatia D, Mehta A, DaCosta J, Crothers O, Talks JS |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8f47d93675f744c3861a108c77860a1a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age
por: Karagiannis D, et al.
Publicado: (2017) -
ANTI-ANGIOGENIC THERAPY IN PATIENTS WITH PATHOLOGIC MYOPIA AND CHOROIDAL NEOVASCULARIZATION
por: S. A. Korotkikh, et al.
Publicado: (2016) -
Intravitreal aflibercept for the treatment of choroidal neovascularization associated with pathologic myopia: a pilot study
por: Korol AR, et al.
Publicado: (2016) -
Multimodal imaging and diagnosis of myopic choroidal neovascularization in Caucasians
por: Milani P, et al.
Publicado: (2016) -
Anti-vascular endothelial growth factor therapy for the treatment of myopic choroidal neovascularization
por: Tan CS, et al.
Publicado: (2017)